Fabrication of gelatin–strontium substituted calcium phosphate scaffolds with unidirectional pores for bone tissue engineering

Journal of Materials Science: Materials in Medicine

Volumn 26, Issue 3, 2015, Pages 1-12

  Wu, Yu Chun ^a   Lin, Wei Yu ^b   Yang, Chyun Yu ^b   Lee, Tzer Min ^b,c  

^a NATIONAL APPLIED RESEARCH LABORATORIES   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CALCIUM CARBIDE; CALCIUM PHOSPHATE; CELL PROLIFERATION; COMPRESSIVE STRENGTH; CRYSTAL STRUCTURE; ENERGY DISPERSIVE SPECTROSCOPY; FABRICATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HYDROXYAPATITE; PORE SIZE; SCANNING ELECTRON MICROSCOPY; STRONTIUM COMPOUNDS; TISSUE;

BONE TISSUE ENGINEERING; CALCIUM PHOSPHATE COMPOUNDS; CALCIUM PHOSPHATE SCAFFOLDS; COMPOSITE SCAFFOLDS; CULTURE CONDITIONS; LONGITUDINAL DIRECTION; OSTEOBLASTIC CELLS; UNIDIRECTIONAL PORES;

SCAFFOLDS (BIOLOGY);

CALCIUM PHOSPHATE; GELATIN; HYDROXYAPATITE; STRONTIUM;

ARTICLE; BONE GRAFT; BULK DENSITY; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; CHEMICAL STRUCTURE; COMPOSITE GRAFT; COMPRESSIVE STRENGTH; CONTROLLED STUDY; CRYSTAL STRUCTURE; DEGRADATION; FREEZE DRYING; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MICRO-COMPUTED TOMOGRAPHY; MICROTECHNOLOGY; OSTEOBLAST; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TENSILE STRENGTH; TISSUE ENGINEERING; TISSUE SCAFFOLD; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; BONE DEVELOPMENT; CELL LINE; CHEMISTRY;

BONE DEVELOPMENT; CALCIUM PHOSPHATES; CELL LINE; CELL PROLIFERATION; GELATIN; HUMANS; MICROSCOPY, ELECTRON, SCANNING; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STRONTIUM; TISSUE ENGINEERING; TISSUE SCAFFOLDS; X-RAY DIFFRACTION;

EID: 84924967336     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-015-5490-7     Document Type: Article

References (42)

1. Yang S, Leong KF, Du Z, Chua CK. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng. 2001;7(6):679–89. doi:10.1089/107632701753337645.
2. Parikh SN. Bone graft substitutes: past, present, future. J Postgrad Med. 2002;48(2):142–8.
3. Sasaki N, Sudoh Y. X-ray pole figure analysis of apatite crystals and collagen molecules in bone. Calcif Tissue Int. 1997;60(4):361–7.
4. Lee SB, Jeon HW, Lee YW, Lee YM, Song KW, Park MH, et al. Bio-artificial skin composed of gelatin and (1 – >3), (1 – >6)-beta-glucan. Biomaterials. 2003;24(14):2503–11.
5. Kuijpers AJ, van Wachem PB, van Luyn MJ, Plantinga JA, Engbers GH, Krijgsveld J, et al. In vivo compatibility and degradation of crosslinked gelatin gels incorporated in knitted Dacron. J Biomed Mater Res. 2000;51(1):136–45.
6. Yung CW, Wu LQ, Tullman JA, Payne GF, Bentley WE, Barbari TA. Transglutaminase crosslinked gelatin as a tissue engineering scaffold. J Biomed Mater Res Part A. 2007;83(4):1039–46. doi:10.1002/jbm.a.31431.
7. Sun L, Berndt CC, Gross KA, Kucuk A. Material fundamentals and clinical performance of plasma-sprayed hydroxyapatite coatings: a review. J Biomed Mater Res. 2001;58(5):570–92.
8. Song J, Xu J, Filion T, Saiz E, Tomsia AP, Lian JB, et al. Elastomeric high-mineral content hydrogel-hydroxyapatite composites for orthopedic applications. J Biomed Mater Res Part A. 2009;89(4):1098–107. doi:10.1002/jbm.a.32110.
9. Kim HW, Kim HE, Salih V. Stimulation of osteoblast responses to biomimetic nanocomposites of gelatin-hydroxyapatite for tissue engineering scaffolds. Biomaterials. 2005;26(25):5221–30. doi:10.1016/j.biomaterials.2005.01.047.
10. Kim HW, Knowles JC, Kim HE. Porous scaffolds of gelatin-hydroxyapatite nanocomposites obtained by biomimetic approach: characterization and antibiotic drug release. J Biomed Mater Res B Appl Biomater. 2005;74(2):686–98. doi:10.1002/jbm.b.30236.
11. Okayama S, Akao M, Nakamura S, Shin Y, Higashikata M, Aoki H. The mechanical properties and solubility of strontium-substituted hydroxyapatite. Bio-Med Mater Eng. 1991;1(1):11–7.
12. 2+) in hydroxyapatite. J Mater Sci. 1998;9(3):129–34.
13. Botelho CM, Brooks RA, Best SM, Lopes MA, Santos JD, Rushton N, et al. Human osteoblast response to silicon-substituted hydroxyapatite. J Biomed Mater Res Part A. 2006;79(3):723–30. doi:10.1002/jbm.a.30806.
14. Landi E, Logroscino G, Proietti L, Tampieri A, Sandri M, Sprio S. Biomimetic Mg-substituted hydroxyapatite: from synthesis to in vivo behaviour. J Mater Sci. 2008;19(1):239–47. doi:10.1007/s10856-006-0032-y.
15. Christoffersen J, Christoffersen MR, Kolthoff N, Barenholdt O. Effects of strontium ions on growth and dissolution of hydroxyapatite and on bone mineral detection. Bone. 1997;20(1):47–54.
16. Morohashi T, Sano T, Yamada S. Effects of strontium on calcium metabolism in rats. I. A distinction between the pharmacological and toxic doses. Jpn J Pharmacol. 1994;64(3):155–62.
17. Zhang W, Shen Y, Pan H, Lin K, Liu X, Darvell BW, et al. Effects of strontium in modified biomaterials. Acta Biomater. 2011;7(2):800–8. doi:10.1016/j.actbio.2010.08.031.
18. Coulombe J, Faure H, Robin B, Ruat M. In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor. Biochem Biophys Res Commun. 2004;323(4):1184–90. doi:10.1016/j.bbrc.2004.08.209.
19. Wong CT, Lu WW, Chan WK, Cheung KM, Luk KD, Lu DS, et al. In vivo cancellous bone remodeling on a strontium-containing hydroxyapatite (sr-HA) bioactive cement. J Biomed Mater Res Part A. 2004;68(3):513–21. doi:10.1002/jbm.a.20089.
20. Ni GX, Lu WW, Chiu KY, Li ZY, Fong DY, Luk KD. Strontium-containing hydroxyapatite (Sr-HA) bioactive cement for primary hip replacement: an in vivo study. J Biomed Mater Res B Appl Biomater. 2006;77(2):409–15. doi:10.1002/jbm.b.30417.
21. Reginster JY, Lecart MP, Deroisy R, Lousberg C. Strontium ranelate: a new paradigm in the treatment of osteoporosis. Expert Opin Investig Drugs. 2004;13(7):857–64. doi:10.1517/13543784.13.7.857.
22. Briot K, Roux C. Strontium ranelate: state of the art. Women’s Health. 2005;1(1):15–21. doi:10.2217/17455057.1.1.15.
23. Rodriguez J, Escudero ND, Mandalunis PM. Effect of strontium ranelate on bone remodeling. Acta odontologica latinoamericana. 2012;25(2):208–13.
24. Yang F, Yang D, Tu J, Zheng Q, Cai L, Wang L. Strontium enhances osteogenic differentiation of mesenchymal stem cells and in vivo bone formation by activating Wnt/catenin signaling. Stem Cells. 2011;29(6):981–91. doi:10.1002/stem.646.
25. Sila-Asna M, Bunyaratvej A, Maeda S, Kitaguchi H, Bunyaratavej N. Osteoblast differentiation and bone formation gene expression in strontium-inducing bone marrow mesenchymal stem cell. Kobe J Med Sci. 2007;53(1–2):25–35.
26. Davidenko N, Gibb T, Schuster C, Best SM, Campbell JJ, Watson CJ, et al. Biomimetic collagen scaffolds with anisotropic pore architecture. Acta Biomater. 2012;8(2):667–76. doi:10.1016/j.actbio.2011.09.033.
27. Madaghiele M, Sannino A, Yannas IV, Spector M. Collagen-based matrices with axially oriented pores. J Biomed Mater Res Part A. 2008;85(3):757–67. doi:10.1002/jbm.a.31517.
28. Wu YC, Lee TM, Chiu KH, Shaw SY, Yang CY. A comparative study of the physical and mechanical properties of three natural corals based on the criteria for bone-tissue engineering scaffolds. J Mater Sci. 2009;20(6):1273–80. doi:10.1007/s10856-009-3695-3.
29. Nikodem A, Scigala K. Impact of some external factors on the values of mechanical parameters determined in tests on bone tissue. Acta Bioeng Biomech Wroclaw Univ Technol. 2010;12(3):85–93.
30. Caverzasio J. Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms. Bone. 2008;42(6):1131–6. doi:10.1016/j.bone.2008.02.010.
31. Lowenstam HA, Weiner S. On biomineralization. New York: Oxford University Press; 1989.
32. Fan H, Ikoma T, Tanaka J, Zhang X. Surface structural biomimetics and the osteoinduction of calcium phosphate biomaterials. J Nanosci Nanotechnol. 2007;7(3):808–13.
33. Yao CH, Liu BS, Chang CJ, Hsu SH, Chen YS. Preparation of networks of gelatin and genipin as degradable biomaterials. Mater Chem Phys. 2004;83(2–3):204–8. doi:10.1016/j.mathchemphys.2003.08.027.
34. Rosellini E, Cristallini C, Barbani N, Vozzi G, Giusti P. Preparation and characterization of alginate/gelatin blend films for cardiac tissue engineering. J Biomed Mater Res Part A. 2009;91(2):447–53. doi:10.1002/jbm.a.32216.
35. Odelius K, Hoglund A, Kumar S, Hakkarainen M, Ghosh AK, Bhatnagar N, et al. Porosity and pore size regulate the degradation product profile of polylactide. Biomacromolecules. 2011;12(4):1250–8. doi:10.1021/bm1015464.
36. Yunoki S, Ikoma T, Tsuchiya A, Monkawa A, Ohta K, Sotome S, et al. Fabrication and mechanical and tissue ingrowth properties of unidirectionally porous hydroxyapatite/collagen composite. J Biomed Mater Res B Appl Biomater. 2007;80(1):166–73. doi:10.1002/jbm.b.30581.
37. Yu H, Matthew HW, Wooley PH, Yang SY. Effect of porosity and pore size on microstructures and mechanical properties of poly-epsilon-caprolactone- hydroxyapatite composites. J Biomed Mater Res B Appl Biomater. 2008;86(2):541–7. doi:10.1002/jbm.b.31054.
38. Guarino V, Causa F, Ambrosio L. Porosity and mechanical properties relationship in PCL porous scaffolds. J Appl Biomater Biomech. 2007;5(3):149–57.
39. Chattopadhyay N, Quinn SJ, Kifor O, Ye C, Brown EM. The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation. Biochem Pharmacol. 2007;74(3):438–47. doi:10.1016/j.bcp.2007.04.020.
40. Xue W, Moore JL, Hosick HL, Bose S, Bandyopadhyay A, Lu WW, et al. Osteoprecursor cell response to strontium-containing hydroxyapatite ceramics. J Biomed Mater Res Part A. 2006;79(4):804–14. doi:10.1002/jbm.a.30815.
41. Boanini E, Torricelli P, Fini M, Bigi A. Osteopenic bone cell response to strontium-substituted hydroxyapatite. J Mater Sci. 2011;22(9):2079–88. doi:10.1007/s10856-011-4379-3.
42. Aina V, Bergandi L, Lusvardi G, Malavasi G, Imrie FE, Gibson IR, et al. Sr-containing hydroxyapatite: morphologies of HA crystals and bioactivity on osteoblast cells. Mater Sci Eng C. 2013;33(3):1132–42. doi:10.1016/j.msec.2012.12.005.